Britain Widens Access To Pfizer’s COVID Antiviral Drug Through Trial
Britain will expand access to Pfizer’s oral antiviral COVID-19 treatment to thousands more people by adding it to a trial to assess how best to use the drug in its highly vaccinated population, the health ministry said on Tuesday.…
Read More...
Read More...